Daiwa upgraded Gilead (GILD) to Outperform from Neutral with a $128 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Gilead Sciences Appoints New Senior Vice President
- Gilead Sciences’ Phase 3 Study on Triple Negative Breast Cancer: A Potential Game-Changer?
- Gilead Sciences: Hold Rating Amidst Strong HIV Performance and Limited Growth Prospects
- Gilead Sciences: Strong Q2 Performance and Promising Yeztugo Launch Support Buy Rating
- Gilead Sciences’ Earnings Call Highlights Growth and Strategic Advances